Consequences of Hyperoxia and the Toxicity of Oxygen in the Lung
William J. Mach,
Amanda R. Thimmesch,
J. Thomas Pierce and
Janet D. Pierce
Nursing Research and Practice, 2011, vol. 2011, 1-7
Abstract:
Oxygen (O 2 ) is life essential but as a drug has a maximum positive biological benefit and accompanying toxicity effects. Oxygen is therapeutic for treatment of hypoxemia and hypoxia associated with many pathological processes. Pathophysiological processes are associated with increased levels of hyperoxia-induced reactive O 2 species (ROS) which may readily react with surrounding biological tissues, damaging lipids, proteins, and nucleic acids. Protective antioxidant defenses can become overwhelmed with ROS leading to oxidative stress. Activated alveolar capillary endothelium is characterized by increased adhesiveness causing accumulation of cell populations such as neutrophils, which are a source of ROS. Increased levels of ROS cause hyperpermeability, coagulopathy, and collagen deposition as well as other irreversible changes occurring within the alveolar space. In hyperoxia, multiple signaling pathways determine the pulmonary cellular response: apoptosis, necrosis, or repair. Understanding the effects of O 2 administration is important to prevent inadvertent alveolar damage caused by hyperoxia in patients requiring supplemental oxygenation.
Date: 2011
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)
Downloads: (external link)
http://downloads.hindawi.com/journals/NRP/2011/260482.pdf (application/pdf)
http://downloads.hindawi.com/journals/NRP/2011/260482.xml (text/xml)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:hin:jnlnrp:260482
DOI: 10.1155/2011/260482
Access Statistics for this article
More articles in Nursing Research and Practice from Hindawi
Bibliographic data for series maintained by Mohamed Abdelhakeem ().